Vegaderm ointment

Composition

Each gram contains:

• Betamethasone Dipropionate BP eq. to Betamethasone 0.1 % w/w;
• Clotrimazole BP 1.5 % w/w;
• Gentamicin Sulfate BP eq. to Gentamicin 0.1 % w/w.

Indications for use

• Skin diseases responsive to local therapy with corticosteroids which have or may develop primary or secondary bacterial infection. Infected allergic and non-allergic skin diseases: acute, subacute and chronic types of contact allergic dermatitis and occupational dermatitis, seborrheic dermatitis, diaper dermatitis, atopic dermatitis (neurodermatitis), intertrigo, eczematous nummular dermatitis, dyshidrotic dermatitis, pyodermatous acute nonallergic dermatitis, acute photodermatitis, x-ray dermatitis, infected dermatitis caused by insect bites;
• Infected dermatoses such as psoriasis vulgaris, exfoliative dermatitis, lichen ruber planus, etc.
• Vegaderm ointment is used on skin lesions infected by bacteria responsive to gentamicin.

Mode of application

Vegaderm ointment is for topical application only. Ointment is beneficial in the treatment of chronic dermatoses, e.g. dry, lichenified and scaly lesions, i.e. in cases when occlusive effect of ointment as vehicle is required. The required amount of ointment is applied to the affected skin in a thin layer and gently rubbed in twice daily. On parts of skin with thick stratum corneum and on which the preparation is easily removed (e.g. palms and soles of the feet) treatment should be repeated more frequently. The treatment should not exceed 3 weeks. In the chronic skin conditions, to prevent relapses, treatment should continue for some time even after the disappearance of all symptoms, under constant supervision of a physician.